NextGen Healthcare Q2 EPS $0.31 Beats $0.25 Estimate, Sales $176.42M Miss $176.95M Estimate
Portfolio Pulse from Happy Mohamed
NextGen Healthcare reported Q2 earnings of $0.31 per share, beating the analyst consensus estimate of $0.25 by 24%. However, the company's quarterly sales of $176.42 million missed the analyst consensus estimate of $176.95 million by 0.30%. This represents a 10.65% increase in sales compared to the same period last year.
October 24, 2023 | 8:40 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
NextGen Healthcare's Q2 earnings beat estimates but sales missed, indicating mixed performance. This could lead to volatility in the stock's price.
NextGen Healthcare's earnings beat estimates, which is a positive signal for investors. However, the company's sales missed estimates, which could be a concern. This mixed performance could lead to volatility in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100